摘要
采用高效液相荧光法(exλ=295um,emλ=340nm)同步检测人尿中萘丁美酮(NAB)的主要代谢物6-甲氧基-2-萘乙酸(MNAA)及褪黑素(MT)。5名男性志愿者于18点口服500mgNAB后,尿中MT累积量仍呈昼夜变化节律,其累积量分别从未服药前的每12小时274.0±58pmol(夜晚)和77.6±25pmol(白天)减少至145.6±32pmol(夜晚)和50.3±12pmol(白天)(P值均小于0.01)。依照尿中的MNAA消除速率对中点时间作曲线,求得MNAAT为22.5h,TPK为14.2h,与已知报告的血浆中数值相近。相关分析证明,MT累积量抑制与MNAA消除速率相关(r=0.9644,P<0.05)。MNAA在尿中96h的累积量仅占口服500mgNAB的3.5%,高于HaddockRE采用同位素得出1%的结论。
The main metabolite of nabumetone(NAB),the 6-methoxy-2-naphthylacetic acid(MNAA),the potent inhibitor of PGs,and physiological secretion of MT in male urine were determinated by HPLC with fluorometric detector(λex=295nm,λem=340nm).The results were shown that after p.o.NAB.at 1800o'clock,the circadian variation of MT levels were still undergoing the nocturnal increase,but the accumulated amount of MT in 5 health male urine were reduced from274±58 pmol/12h (N)and 77.6±25 pmol/12h(D)to 145.6 ±32 pmol/12 h,50.3± 12 pmol/12 h respectively.Accounting to the curve of elimination rate vs the middle time, we got the TPK=14.2hr that were close to the value in plasma.The regression analysis was shown that the inhibition degree of MT was correlated to the elimination rate of MNAA.(r=0.9644,P<0.05).The accumulated amount of free MNAA during 96 hr in urine was accounting for 3.5% dose of 500 mg NAB.higher than 1.0% reported by Haddock R.E.using isotope. We suppose that even if MNAA does not structurally resemble MT or indomethacin,but it still might interrupt MT synthesls via PGs.
出处
《中国药理学通报》
CAS
CSCD
北大核心
1994年第6期453-457,共5页
Chinese Pharmacological Bulletin
关键词
萘丁美酮
褪黑素
高效液相色谱
MNAA
Nabumetone
Melatonin
HPLC
6-methoxy-2-naphthylacetic acid
Pharmacokinetcs